AIM IMMUNOTECH INC.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2016 | $-1.0M | $-1.0M | — | — |
| Jun 2016 | $-1.2M | $-1.2M | — | — |
| Sep 2016 | $-3.0M | $-3.0M | — | — |
| Mar 2017 | $-3.0M | $-3.0M | $3.0K | — |
| Jun 2017 | $-2.3M | $-2.3M | $0 | — |
| Sep 2017 | $-1.9M | $-1.9M | $17.0K | — |
| Mar 2018 | $-2.5M | $-2.5M | — | $286.0K |
| Jun 2018 | $-2.7M | $-2.7M | — | — |
| Sep 2018 | $-3.0M | $-3.0M | — | — |
| Mar 2019 | $-1.5M | $-1.5M | $14.0K | $175.0K |
| Jun 2019 | $-2.8M | $-2.8M | $49.0K | — |
| Sep 2019 | $-2.5M | $-2.5M | $5.0K | — |
| Mar 2020 | $-3.3M | $-3.3M | $7.0K | $196.0K |
| Jun 2020 | $-1.3M | $-1.3M | $2.0K | — |
| Sep 2020 | $-3.0M | $-3.0M | $4.0K | — |
| Mar 2021 | $-3.0M | $-3.0M | — | $526.0K |
| Jun 2021 | $-1.7M | $-1.7M | — | — |
| Sep 2021 | $-3.5M | $-3.5M | — | — |
| Mar 2022 | $-2.8M | $-2.8M | — | $242.0K |
| Jun 2022 | $-2.3M | $-2.3M | — | — |
| Sep 2022 | $-5.0M | $-5.0M | — | — |
| Mar 2023 | $-3.7M | $-3.7M | — | $82.0K |
| Jun 2023 | $-2.2M | $-2.2M | — | $50.0K |
| Sep 2023 | $-5.7M | $-5.7M | — | $50.0K |
| Mar 2024 | $-4.8M | $-4.8M | — | $80.0K |
| Jun 2024 | $-3.0M | $-3.0M | — | $80.0K |
| Sep 2024 | $-3.1M | $-3.1M | — | $80.0K |
| Mar 2025 | $-2.4M | $-2.4M | — | $60.0K |
| Jun 2025 | $-1.5M | $-1.5M | — | — |
| Sep 2025 | $-5.1M | $-5.1M | — | — |